Clinical Trial Detail

NCT ID NCT02621398
Title Pembrolizumab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-IIIB Non-Small Cell Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Rutgers, The State University of New Jersey
Indications

lung non-small cell carcinoma

Therapies

Carboplatin + Paclitaxel + Pembrolizumab

Age Groups: adult

No variant requirements are available.